Mary Procaccio-Flowers

Specialty / focus. During her private-practice years, Mary Procaccio-Flowers's IP litigation work spanned both high-tech and pharmaceutical matters: cellular communications standards, digital and analog circuitry, digital signal processors, power-over-Ethernet, internet security software, home security/monitoring software, and pharmaceuticals, before federal, state, and appellate courts as well as the ITC (Wilson Sonsini bio; LawTally profile). Her only tracked appearance — Novartis Pharmaceuticals Corp. v. Apotex Inc., where she appeared pro hac vice for defendant Apotex while at Wilson Sonsini — is a Hatch-Waxman/ANDA-style pharma dispute and points to a defendant-side orientation. The sample is small, but a related Delaware docket shows her later serving as Novartis's WSGR co-counsel in Novartis v. Accord Healthcare (No. 1:18-cv-01043, removed Oct. 2019), so she handled both sides of pharma patent litigation.

Firm context / notable cases. She began her career at Wilson Sonsini Goodrich & Rosati (associate, Sept. 2012 – July 2020), co-chairing the firm's Associates Committee (WSGR announcement; Santa Clara Law faculty page). She is no longer in private practice: after two ND Cal clerkships (2019–20 and from Jan. 2025) and teaching IP litigation at Santa Clara University School of Law, Governor Newsom appointed her to the Santa Clara County Superior Court in April 2026; she was sworn in May 26, 2026 (WSGR; court announcement). The tracked Novartis v. Apotex appearance therefore reflects her WSGR tenure; I could not verify that case's outcome from available sources. Note that the widely reported Canadian decisions bearing the same party names (Novartis Pharmaceuticals Canada Inc. v. Apotex Inc., 2013 FC 141/142, the Gleevec/imatinib cases) are separate Canadian proceedings and should not be attributed to her.

PTAB / bar / education. I found no verifiable record of PTAB or IPR/PGR appearances; her documented practice centered on district court, ITC, and appellate litigation. She is a member of the California Bar (No. 286936, admitted 2012) and is admitted to the N.D., C.D., and S.D. of California and E.D. of Texas; J.D., Santa Clara University School of Law (summa cum laude, 2012); B.A. in Integrative Biology, UC Berkeley (Justia; State Bar of California).